BACKGROUND: Dysmorphology is more concentrated in the craniofacial region of Schizophrenic Patients. So, an early anthropometric assessment of the physical dimensions of the cranium and the face may indicate a potential clue of Schizophrenia. AIMS: To study the craniofacial dysmorphology in schizophrenic patients and in healthy controls of the Agra region and to find out whether its evaluation could be used as a tool in the early diagnosis of schizophrenia. SETTING AND DESIGN: This was a case-control, cross-sectional study. SUBJECTS AND METHODS: Schizophrenic Patients well diagnosed by consultant psychiatrists on the basis of the DSM IV criteria of the S.N. Medical College Agra and the Institute of Mental health, Agra and healthy controls of Agra were selected for the study. The total facial height (trichion to gnathion), the upper facial height (trichion to subnasale) and the lower facial height (subnasale to gnathion) were measured among the various groups of patients and the controls. The mean data were statistically correlated by using the t test for the independent variables. RESULTS: The total facial height (trichion to gnathion) was elongated in the Schizophrenic male patients as compared to the controls. When we compared the schizophrenic patients on the basis of the family history of schizophrenia, it was found that there was an elongation of the total facial height in the patients with a positive family history of schizophrenia as compared to the patients without a family history of schizophrenia. There was also a significant elongation of the upper facial height (trichion to subnasale ) in the schizophrenic male and female patients. CONCLUSIONS: There was total facial elongation and upper facial region elongation in the schizophrenia patients as compared to the controls.
BACKGROUND: Dysmorphology is more concentrated in the craniofacial region of SchizophrenicPatients. So, an early anthropometric assessment of the physical dimensions of the cranium and the face may indicate a potential clue of Schizophrenia. AIMS: To study the craniofacial dysmorphology in schizophrenicpatients and in healthy controls of the Agra region and to find out whether its evaluation could be used as a tool in the early diagnosis of schizophrenia. SETTING AND DESIGN: This was a case-control, cross-sectional study. SUBJECTS AND METHODS: SchizophrenicPatients well diagnosed by consultant psychiatrists on the basis of the DSM IV criteria of the S.N. Medical College Agra and the Institute of Mental health, Agra and healthy controls of Agra were selected for the study. The total facial height (trichion to gnathion), the upper facial height (trichion to subnasale) and the lower facial height (subnasale to gnathion) were measured among the various groups of patients and the controls. The mean data were statistically correlated by using the t test for the independent variables. RESULTS: The total facial height (trichion to gnathion) was elongated in the Schizophrenic malepatients as compared to the controls. When we compared the schizophrenicpatients on the basis of the family history of schizophrenia, it was found that there was an elongation of the total facial height in the patients with a positive family history of schizophrenia as compared to the patients without a family history of schizophrenia. There was also a significant elongation of the upper facial height (trichion to subnasale ) in the schizophrenic male and female patients. CONCLUSIONS: There was total facial elongation and upper facial region elongation in the schizophreniapatients as compared to the controls.
Authors: John McGrath; Ossama El-Saadi; Vivian Grim; Sue Cardy; Ben Chapple; David Chant; Daniel Lieberman; Bryan Mowry Journal: Arch Gen Psychiatry Date: 2002-05
Authors: J Elizarrarás-Rivas; R Fragoso-Herrera; L F Cerdán-Sánchez; R Ramos-Zepeda; L O Barajas-Barajas; R Troyo-Sanromán; D McLean; J J McGrath Journal: Schizophr Res Date: 2003-08-01 Impact factor: 4.939
Authors: Karin Maria Henriksson; Karin Wickstrom; Nils Maltesson; Anders Ericsson; Johan Karlsson; Finn Lindgren; Kalle Astrom; Thomas Farrell McNeil; Ingrid Agartz Journal: Psychiatry Res Date: 2006-09-01 Impact factor: 3.222
Authors: Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington Journal: Biol Psychiatry Date: 2007-01-09 Impact factor: 13.382
Authors: A Lane; A Kinsella; P Murphy; M Byrne; J Keenan; K Colgan; B Cassidy; N Sheppard; R Horgan; J L Waddington; C Larkin; E O'Callaghan Journal: Psychol Med Date: 1997-09 Impact factor: 7.723
Authors: Peter F Buckley; David Dean; Fred L Bookstein; Seungho Han; Michael Yerukhimovich; Kyoung-June Min; Beth Singer Journal: Am J Psychiatry Date: 2005-03 Impact factor: 18.112
Authors: Michael T Compton; Jennifer Brudno; Aimee D Kryda; Annie M Bollini; Elaine F Walker Journal: Schizophr Res Date: 2007-04-24 Impact factor: 4.939